Marijuana Use and Adherence to Smoking Cessation Treatment Among Callers to Tobacco Quitlines.


Journal

Preventing chronic disease
ISSN: 1545-1151
Titre abrégé: Prev Chronic Dis
Pays: United States
ID NLM: 101205018

Informations de publication

Date de publication:
10 09 2020
Historique:
entrez: 11 9 2020
pubmed: 12 9 2020
medline: 20 7 2021
Statut: epublish

Résumé

Tobacco kills over half a million adults annually in the United States. Most smokers want to quit, and over 400,000 call state-funded quitlines for help each year. Marijuana use among tobacco users is common and may impede quitting, but co-use rates among quitline callers are unknown. The purpose of our observational study was to describe marijuana use among quitline callers in states with legalized marijuana. Participants were 1,059 smokers aged 21 or older from Oregon, Alaska, and Washington, DC, who called quitlines from September through December 2016. Data on quitline callers' demographics, tobacco and marijuana use, and quitline use were collected. We used χ Among quitline callers in our study, 24% reported using marijuana in the past 30 days: 28.9% in Alaska, 16.7% in Washington, DC, and 25.0% in Oregon (P = .009). Current users, compared with non-users (n = 772), were less likely to be women (48.4% vs 62.0%, respectively, P < .001). Current marijuana users were less likely to be given nicotine replacement therapy (68.4%) than current nonusers (74.1%) (P < .001), but more likely to complete 3 or more counseling calls (P = .005). Of those who used marijuana in the past 30 days, 62.3% used marijuana on 1 to 19 days, 9.0% used on 20 to 29 days, and 28.7% on all 30 days. Among current marijuana users, the percentage who wanted to quit or reduce marijuana use (42.6%) was higher in Alaska (54.6%) and the District of Columbia (56.8%) than in Oregon (37.9%), P = .03. One in 4 quitline callers reported past 30-day marijuana use. Given that nearly half (43%) wanted to reduce marijuana use, addressing co-use may be an important addition to quitline treatment. Future studies should assess co-use effects on tobacco cessation outcomes and explore combined treatment or bidirectional referrals between quitlines and marijuana treatment providers.

Identifiants

pubmed: 32915131
doi: 10.5888/pcd17.200110
pii: E102
pmc: PMC7553215
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

E102

Références

Drug Alcohol Depend. 2008 Jun 1;95(3):199-208
pubmed: 18339491
Ann Intern Med. 2018 Dec 18;169(12):890-892
pubmed: 30167665
Addict Behav. 2015 Oct;49:26-32
pubmed: 26036666
JAMA. 2014 Jan 8;311(2):172-82
pubmed: 24399556
Cochrane Database Syst Rev. 2013 Aug 12;(8):CD002850
pubmed: 23934971
Nicotine Tob Res. 2016 Mar;18(3):281-8
pubmed: 26009578
Am J Prev Med. 2016 Jan;50(1):1-8
pubmed: 26277652
Drug Alcohol Depend. 2014 Aug 1;141:159-62
pubmed: 24928480
Am J Prev Med. 2008 Aug;35(2):158-76
pubmed: 18617085
J Adolesc Health. 2014 Feb;54(2):235-40
pubmed: 24119417
J Med Internet Res. 2008 Nov 14;10(5):e41
pubmed: 19017583
N Engl J Med. 2002 Oct 3;347(14):1087-93
pubmed: 12362011
Exp Clin Psychopharmacol. 2019 Jun;27(3):265-275
pubmed: 30556733
Addict Behav. 2019 Mar;90:354-361
pubmed: 30522075
Nicotine Tob Res. 2020 Jul 16;22(8):1404-1408
pubmed: 31112595

Auteurs

Kelly M Carpenter (KM)

Center for Wellbeing Research, Optum, PO BOX 9472, Minneapolis, MN 55440-9472. Email: Kelly.Carpenter@optum.com.

Alula J Torres (AJ)

Center for Wellbeing Research, Optum, Minneapolis, Minnesota.

Erica E Salmon (EE)

Center for Wellbeing Research, Optum, Minneapolis, Minnesota.

Beatriz H Carlini (BH)

Alcohol and Drug Abuse Institute, University of Washington, Seattle, Washington.

Katrina A Vickerman (KA)

Center for Wellbeing Research, Optum, Minneapolis, Minnesota.

Gillian L Schauer (GL)

University of Washington, School of Public Health, Seattle, Washington.

Terry Bush (T)

Center for Wellbeing Research, Optum, Minneapolis, Minnesota.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH